bluebird bio, Inc. Business Operations Contracts & Agreements
20 Contracts & Agreements
- Collaboration Agreements (4 contracts)
- Development Agreements (1)
- Indemnification Agreements (1)
- Sales Agreements (1)
- Services Agreements (7)
- Supply Agreements (6)
- Commercial Manufacturing Services Agreement, dated November 3, 2017, by and between the Registrant and Thermo Fisher (successor in interest to Henogen SA) (Filed With SEC on September 13, 2024)
- Development and Manufacturing Services Agreement, dated February 28, 2012, by and between the Registrant and Minaris Regenerative Medicine, LLC (formerly known as Hitachi Advanced... (Filed With SEC on September 13, 2024)
- Amendment No. 6 to Clinical and Commercial Supply Agreement Viral Vector Product by and between the Registrant and SAFC Carlsbad, Inc (Filed With SEC on September 13, 2024)
- Second Amendment to Master Manufacturing Services Agreement, dated September 21, 2023, by and between the Registrant and Lonza Houston, Inc (Filed With SEC on November 7, 2023)
- Sales Agreement, dated as of August 8, 2023, by and between bluebird bio, Inc. and Jefferies LLC (Filed With SEC on August 8, 2023)
- Amendment to Master Manufacturing Services Agreement, dated (Filed With SEC on March 29, 2023)
- Master Manufacturing Services Agreement, dated June 3, 2016, by and between the Registrant and Lonza Houston, Inc (Filed With SEC on March 29, 2023)
- Amendment No. 4 to Clinical and Commercial Supply Agreement Viral Vector Product by and between bluebird bio (Switzerland) GmbH and SAFC Carlsbad, Inc (Filed With SEC on August 4, 2022)
- Amendment No. 3 to Clinical and Commercial Supply Agreement Viral Vector Product by and between bluebird bio (Switzerland) GmbH and SAFC Carlsbad, Inc (Filed With SEC on February 23, 2021)
- Amendment Agreement No. 3 to the Toll Manufacturing and Service Agreement by and between bluebird bio (Switzerland) GmbH and Apceth Biopharma GmbH (Filed With SEC on March 12, 2020)
- Amendment No. 2 to Clinical and Commercial Supply Agreement Viral Vector Product by and between bluebird bio (Switzerland) GmbH and SAFC Carlsbad, Inc (Filed With SEC on January 21, 2020)
- Clinical and Commercial Supply Agreement Viral Vector Product, dated November 27, 2017, by and between the Registrant and SAFC Carlsbad, Inc., as amended (Filed With SEC on August 1, 2019)
- Toll Manufacturing and Service Agreement, dated November 18, 2016 by and between the Registrant and APCETH Biopharma GmbH, as amended (Filed With SEC on August 1, 2019)
- Clinical and Commercial Supply Agreement Viral Vector Product, dated November 27, 2017, by and between the Registrant and SAFC Carlsbad, Inc (Filed With SEC on February 21, 2019)
- Toll Manufacturing and Service Agreement, dated November 18, 2016, by and between the Registrant and APCETH Biopharma GmbH (Filed With SEC on February 21, 2019)
- Amendment No. 2 to Amended and Restated Master Collaboration Agreement by and between the Registrant and Celgene Corporation, dated September 28, 2017 (Filed With SEC on November 1, 2017)
- Amendment No. 1 to Amended and Restated Master Collaboration Agreement (Filed With SEC on May 4, 2016)
- Master Collaboration Agreement by and between bluebird bio, Inc. and Celgene Corporation March 19, 2013 (Filed With SEC on May 21, 2013)
- Master Collaboration Agreement by and between bluebird bio, Inc. and Celgene Corporation March 19, 2013 (Filed With SEC on May 14, 2013)
- FORM OF INDEMNIFICATION AGREEMENT BLUEBIRD BIO, INC. Indemnification Agreement (Filed With SEC on May 14, 2013)
